Literature DB >> 27788631

Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.

Cinzia S Keechilot1, Veena Shenoy2, Anil Kumar3, Lalitha Biswas4, Sukhithasri Vijayrajratnam5, Kavitha Dinesh3, Prem Nair6.   

Abstract

With the introduction of highly sensitive hepatitis B surface antigen immunoassay, transfusion associated HBV infection have reduced drastically but they still tend to occur due to blood donors with occult hepatitis B infection (OBI) and window period (WP) infection. Sera from, 24338 healthy voluntary blood donors were screened for HBsAg, HIV and HCV antibody using Vitros Enhanced Chemiluminescent Immunoassay. The median age of the donor population was 30 (range 18-54) with male preponderance (98%). All serologically negative samples were screened by nucleic acid testing (NAT) for viral DNA and RNA. NAT-positive samples were subjected to discriminatory NAT for HBV, HCV, and HIV and all samples positive for HBV DNA were tested for anti-HBc, anti-HBs, HBeAg. Viral load was determined using artus HBV RG PCR Kit. Of the 24,338 donors screened, 99.81% (24292/24338) were HBsAg negative of which NAT was positive for HBV DNA in 0.0205% (5/24292) donors. Four NAT positive donors had viral load of <200 IU/ml making them true cases of OBI. One NAT positive donor was negative for all antibodies making it a case of WP infection. Among OBI donors, 75% (3/4) were immune and all were negative for HBeAg. Precise HBV viral load could not be determined in all (5/5) NAT positive donors due to viral loads below the detection limit of the artus HBV RG PCR Kit. The overall incidence of OBI and WP infections was found to be low at 1 in 6503 and 1 in 24214 donations, respectively. More studies are needed to determine the actual burden of WP infections in Indian blood donors.

Entities:  

Keywords:  Anti-HBc; HBV; Nucleic acid testing; Occult hepatitis B virus infection

Mesh:

Substances:

Year:  2016        PMID: 27788631      PMCID: PMC5189866          DOI: 10.1080/20477724.2016.1248171

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  22 in total

Review 1.  Assessing the impact of HBV NAT on window period reduction and residual risk.

Authors:  Steven H Kleinman; Michael P Busch
Journal:  J Clin Virol       Date:  2006-05       Impact factor: 3.168

Review 2.  Hepatitis B virus infection and transfusion medicine: science and the occult.

Authors:  F Blaine Hollinger
Journal:  Transfusion       Date:  2008-05       Impact factor: 3.157

3.  Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.

Authors:  Mohammad Asim; Riyasat Ali; Luqman A Khan; S A Husain; Rajiv Singla; P Kar
Journal:  Indian J Med Res       Date:  2010-09       Impact factor: 2.375

4.  Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; Cheuk-Kwong Lee; Yasuhito Tanaka; Jean-Pierre Allain; James Fung; Jennifer Leung; Che-Kit Lin; Masaya Sugiyama; Fuminaka Sugauchi; Masashi Mizokami; Ching-Lung Lai
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

Review 5.  Transfusion-transmitted hepatitis B virus infection.

Authors:  Daniel Candotti; Jean-Pierre Allain
Journal:  J Hepatol       Date:  2009-06-10       Impact factor: 25.083

6.  The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.

Authors:  Meng-Hua Yang; Lei Li; Ying-Shen Hung; Cheng-Shen Hung; Jean-Pierre Allain; Kuo-Sin Lin; Su-Jen Lin Tsai
Journal:  Transfusion       Date:  2009-08-26       Impact factor: 3.157

7.  Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.

Authors:  Prasun Bhattacharya; Partha-Kumar Chandra; Sibnarayan Datta; Arup Banerjee; Subhashish Chakraborty; Krishnan Rajendran; Subir-Kumar Basu; Sujit-Kumar Bhattacharya; Runu Chakravarty
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

Review 8.  Clinical impact of occult HBV infections.

Authors:  I Chemin; C Trépo
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

9.  Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!

Authors:  R N Makroo; Mohit Chowdhry; Aakanksha Bhatia; Bhavna Arora; N L Rosamma
Journal:  Asian J Transfus Sci       Date:  2012-01

10.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more
  5 in total

Review 1.  Genosensors as an alternative diagnostic sensing approaches for specific detection of virus species: A review of common techniques and outcomes.

Authors:  Abouzar Babaei; Amir Pouremamali; Nastaran Rafiee; Hessamaddin Sohrabi; Ahad Mokhtarzadeh; Miguel de la Guardia
Journal:  Trends Analyt Chem       Date:  2022-05-19       Impact factor: 14.908

2.  Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B.

Authors:  Anitha Madhavan; Arun Sachu; Anu Kumar Balakrishnan; Sobha Balakrishnan; Jayalakshmi Vasudevapanicker
Journal:  J Lab Physicians       Date:  2021-05-19

3.  Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection.

Authors:  Mahua Sinha; Keerthana Sundar; C S Premalata; Vikas Asati; Alka Murali; Akhilesh Kumar Bajpai; Sravanthi Davuluri; Kshitish K Acharya; K C Lakshmaiah; Govind Babu K; Linu A Jacob; Dharam Nandan; Dinesh Velayutham; Sibnarayan Datta; R S Jayshree
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

4.  Frequency of Hepatitis B, C and HIV Infections among Transfusion-Dependent Beta Thalassemia Patients in Dhaka.

Authors:  Golam Sarower Bhuyan; Aftab Uz Zaman Noor; Rosy Sultana; Farjana Akther Noor; Nusrat Sultana; Suprovath Kumar Sarker; Muhammad Tarikul Islam; Md Abu Sayeed; Md Imam Ul Khabir; A K M Ekramul Hossain; Zebunnesa Zeba; Syeda Kashfi Qadri; Md Ruhul Furkan Siddique; Syed Saleheen Qadri; Firdausi Qadri; Kaiissar Mannoor
Journal:  Infect Dis Rep       Date:  2021-01-15

5.  Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with β-Thalassemia Major in Northern West Bank, Palestine.

Authors:  Kamal Dumaidi; Amer Al-Jawabreh; Fekri Samarah; Maha Rabayaa
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-09-05       Impact factor: 2.471

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.